Respiratory distress after use of droperidol for agitation.
Heard
K
K
Daly
F F
FF
O'Malley
G
G
Rosen
N
N
D000328:Adult; D017109:Akathisia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D000928:Antidepressive Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy; D004329:Droperidol / Q000009:adverse effects*; D004417:Dyspnea / Q000139:chemically induced* / Q000628:therapy; D004638:Emergency Treatment; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects*; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects*; D008297:Male; D017366:Serotonin Receptor Agonists / Q000009:adverse effects*; D020230:Serotonin Syndrome / Q000139:chemically induced* / Q000628:therapy
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D017366:Serotonin Receptor Agonists; D016651:Lithium Carbonate; D008238:Lysergic Acid Diethylamide; D004329:Droperidol